Brainstorm Cell Therapeutics Inc (BCLI) Dividend
Brainstorm Cell Therapeutics Inc (BCLI) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -65.2%. View its historical dividend record below and compare with dividend-paying peers.
Frequently Asked Questions: BCLI Dividend
Does Brainstorm Cell Therapeutics Inc (BCLI) pay a dividend?
Brainstorm Cell Therapeutics Inc (BCLI) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.
Why doesn't Brainstorm Cell Therapeutics Inc pay a dividend?
Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Brainstorm Cell Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -65.2% over the past 3 years.
What are dividend-paying alternatives to Brainstorm Cell Therapeutics Inc?
For dividend-paying alternatives in Brainstorm Cell Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.